Abstract: Objective To explore the changes of endostatin (a strong anti-angiogenesis factor) and vascular endothelial growth factor (VEGF) in the brain tissues of rabbits following cerebral ischemia induced by middle cerebral artery occlusion (MCAO). Methods Twenty-four New Zealand white rabbits were randomly divided into 5 groups: control (n = 5), sham-operation (n = 4), 2-hour ischemia (n = 5), 24-hour ischemia (n = 5), and 48-hour ischemia (n = 5). The expression of VEGF and endostatin were measured by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry, respectively. In situ hybridization was used to characterize the expression of mRNA for the endostatin. Results Both the protein (at least 50%, P < 0.01) and mRNA (at least 70%, P < 0.05) of endostatin increased significantly in the ischemic brain tissues after MCAO compared with the control group. VEGF increased at least 270% in the brain after cerebral ischemia (P < 0.05). Conclusion Cerebral ischemia leads to an up-regulation of endostatin in the brain, which is not associated with the increase of VEGF in the brain. The increase of endostatin may serve as a deleterious mechanism for ischemic injury through blocking angiogenesis.
Introduction
Angiogenesis, sprouting of capillaries from preexisting blood vessels, has been shown to increase brain tissue perfusion and improve functional outcome after cerebral ischemia [1, 2] . But angiogenesis is a complex process including different phases: sprouting, formation, and maturation. It has been demonstrated that this complicated mechanism is modulated by several pro-angiogenic and anti-angiogenic molecules [3, 4] . The endogenous angiogenic response is the result of the balance between pro-angiogenic factors and anti-angiogenic factors. There are many reports on the expression of pro-angiogenic factors in the infarct regions of different animal models and their neuroprotective effects following cerebral ischemia [5] [6] [7] [8] [9] . However, there are no reports on the expression of anti-angiogenic factors so far. The relationship between the pro-and anti-angiogenic factors is not known either. In present study, we measured the expressions of endostatin (an important anti-angiogenic factor) and vascular endothelial growth factor (VEGF, a known proangiogenic factor) in the ischemic brain tissues of rabbits after middle cerebral artery occlusion (MCAO) to determine whether the releases of endostatin and VEGF are related to the focal cerebral ischemia.
Materials and methods

Experimental groups and ischemia model
Twentyfour New Zealand white male rabbits (2.5-3.0 kg) were randomly divided into 5 groups: control (n = 5), shamoperation (n = 4), 2-hour ischemia (n = 5), 24-hour ischemia (n = 5), 48-hour ischemia (n = 5).
In the three ischemia groups, animals were anesthetized with sodium pentobarbital (30 mg/kg, i.v.). Unilateral femoral artery was catheterized to monitor arterial blood pressure and to obtain blood samples for analyses of blood gases, pH, and glucose. Blood gases were analyzed once during the operation. Animals were given a 30% O 2 / 70% NO 2 gas mixture to maintain the P a O 2 above 90 mmHg. Body temperature was measured with a rectal probe and maintained at (37 -37.5) ºC with a heating pad. MCAO was performed according to the method described by O'Brien et al. with a minor modification [10] . The middle cerebral artery (MCA) was exposed at its origin. A small wire hook was inserted under the unilateral MCA, and then the MCA was blocked by the bipolar electric coagulation and cut at its origin. In the sham-operation group, the same lateral MCA as in the ischemia groups was exposed without electrocoagulation , followed by wound closure. In the control group, animals did not undergo any surgical operation.
Brain sections preparation
The surgically treated rabbits were anesthetized by intravenous injection of sodium pentobarbital (30 mg/kg) and sacrificed by decapitation at 2 h (n = 5), 24 h (n = 5), or 48 h (n = 5) after MCAO. The sham-operated rabbits were sacrificed at 24 h after craniotomy. After decapitation, each rabbit's brain was quickly removed. A 5-mm-thick coronal slice centered on the MCA was cut out, frozen in dry ice, and then stored at -70 ºC. 2.3 Enzyme-linked immunosorbent assay (ELISA) for determination of VEGF VEGF was quantified using commercially available immunoassay kits (BPB Biomedicals, Inc., USA) according to the manufacture's instructions. Firstly, keep the desired number of coated wells in the holders. After 100 μL of standards was dispensed into appropriate wells, 100 μL homogenate of the brain tissues, which were obtained from the ischemic penumbra zone in the ischemia groups or the same area in the control group, was also dispensed into appropriate wells. Then 50 μL of enzyme conjugate reagent was dispensed into each well. The mixture was incubated at (18 -25) ºC for 90 min. The microtiter plate was rinsed with distilled water for 6 times, then 50 μL of color A and color B reagent were dispensed into each well. After the samples were incubated at (18 -25) ºC for 15 min, 50 μL of stop solution was added and mixed gently for 30 s to stop the reaction. Finally, a microtiter plate reader was used to read the optical density (OD) at 450 nm.
Immunohistochemistry for detection of endostatin protein
Brain tissues were obtained from the ischemic penumbra zone in the ischemia groups or the same area in the control group. All samples were sectioned at 4 μm with a cryostat. After air dried, the sections were rinsed in 0.1 mol/L PBS for 3 min for 3 times and incubated in 3% hydrogen peroxide at room temperature for 20 min to prevent their reaction with endogenous peroxidases. After rinsed in PBS, brain sections were incubated with primary antibodies (rat anti-rabbit endostatin antibody 1:200; Zymed Inc., USA) at room temperature for 4 h, and then incubated with secondary antibodies goat anti-rat IgG conjugate biotin (1:200) at 37 ºC for 30 min. The sections were then rinsed in 0.1 mol/L PBS, incubated with streptavidinhorseradish peroxidase (streptavidin-HRP, 1:200) at 37 ºC for 30 min, and stained with 0.05% DAB + 0.03% H 2 O 2 for 10 min. After rinsed in PBS, the sections were mounted and coverslipped.
2.5
In situ hybridization (ISH) for measurement of endostatin mRNA Fresh-frozen tissues were cut into 4 μm thin sections in RNase-free environment with a cryostat, and thawed on object-slides. After rinsing in o.1 mol/L PBS for 3 min for 3 times, the sections were incubated in 2 μg/mL protease K for 20 min at 37 ºC, and then rinsed with 0.1 mol/L glycine for 10 min. The sequence of the probes was obtained from the GeneBank database and synthesized by Shanghai Shenggong Biology Project Inc. The forward and reverse primers were 5'-TGG GGC TGG CGG GCA CCT TC-3' and 5'-TCT CGG TCA GCC TGC GCC CG-3', respectively. The probes were labeled at the 3'-end with digoxin and hybridized with the sections following pre-hybridization for 12 h at 48 ºC. After that, the sections were washed sequentially in 2 × SSC, 1× SSC, 0.5 × SSC, and 0.1 × SSC for 10 min each for several times at room temperature. Then the sections were incubated at 37 ºC with anti-Dig IgG (1:500) for 1 h and with streptavidin-HRP (1:200) for 40 min, and stained with 0.04% DAB + 0.05% H 2 O 2 for 10 min. Finally, the sections were washed in distilled water for 5 min and coverslipped.
Image analysis
The sections were examined under an Olympus BH2 microscope and their photos were captured with a Nikon digital camera.
The method is based on the principle that the expression level of endostatin is in direct ratio to the endostatinpositive areas and the OD values of endostatin-positive cells, both of which can be measured to quantitate the mRNA and protein expression of endostatin. Three optical fields were randomly selected from each section, and the values were averaged.
Image analysis was performed with medical image analysis system (Shanghai Shenteng Information Technology Inc., China).
Statistical analysis
Data were expressed as mean ± SEM. Statistical differences between the normal control and other groups were compared by one-way ANOVA test. A linear correlation model was used to determine whether there was an association between VEGF and endostatin. P < 0.05 was considered statistically significant. All data were analyzed with SAS 6.22.
Results
All physiological parameters were within normal range. There were no significant differences between the control group and the MCAO ischemia groups in mean arterial blood pressure, blood gases (P a O 2 , P a CO 2 and HCO 3 -), pH and glucose.
3.1 VEGF levels in the brain tissue after MCAO ELISA measurement revealed that VEGF in the ischemia groups was significantly higher than that in the control group. VEGF started to increase at 2 h, remained at 24 h and 48 h, and peaked at 48 h after MCAO. No difference was observed between the sham-operation group and the control group (Tab.1).
Expression of endostatin protein in the ischemic areas after MCAO
By immunohistochemical staining, in the brain samples of normal rabbits, weak staining of endogenous endostatin was observed. After ischemia insult, the expression of endogenous endostatin was enhanced at 2 h, 24 h, and 48 h after MCAO and peaked at 2 h after MCAO; no difference was observed between the sham-operation group and the control group (Tab.2, Fig. 1 ).
Up-regulation of endostatin mRNA in the ischemic areas after MCAO
With ISH and image analysis, we were able to detect the alteration of expression of endostatin mRNA. Paralleling endogenous endostatin protein, the expression of endostatin mRNA increased at 2 h, 24 h, and 48 h after ischemia insult, no difference was observed between the sham-operation group and the control group (Tab. 3, Fig. 2 ). Higher increment of endostatin mRNA was at 48 h after MCAO (Fig. 1) . 
The relationship between VEGF and endostatin after MCAO
Discussion
Angiogenesis may play an important role in ischemic, inflammatory diseases and wound healing. The modulation of angiogenesis may be one of the most efficient approaches to brain cellular recovery in the pathological and physiological processes following focal cerebral ischemia. Therefore, targeting the formation of blood vessels is regarded as a promising strategy in cerebral ischemia therapy. However, angiogenesis is a complex process, comprising activation, proliferation and migration of endothelial cells, alteration of the extracellular matrix, formation of endothelial tubes, and their linkage to preexisting vascular networks. This complicated mechanism is modulated by several proangiogenic and anti-angiogenic molecules [3, 11] . VEGF is the strongest pro-angiogenic factor and plays an important role in the morphogenesis of angiogenesis [12] . It has been reported that hypoxia-induced VEGF expression precedes neovascularization in the border zone of the ischemic neocortex in the rodent [13] . Following transient or permanent MCAO in the rats, VEGF and its receptors expression increased in the peri-infarct regions [14, 15] . Overexpression of VEGF can be induced by injection of VEGF plasmids, which can reduce infarct volumes and protect tissues against ischemic injury [7, 16] . Administration of VEGF has been regarded as a beneficial treatment for cerebral ischemia. In agreement with previous studies, we found VEGF to be significantly increased in penumbra zone of ischemia after MCAO. Nevertheless, the role of anti-angiogenic factors such as endostatin in cerebral ischemia was less known. Endostatin is a 20 kDa protein fragment derived from the C-terminal region of collagen XVIII and may be one of the most potent endogenous angiogenesis inhibitors known [17] . Some studies have shown the effect of endostatin on inhibiting proliferation and migration of endothelial cells, inducing apoptosis, and inhibiting angio- genesis [17] [18] [19] . Recently, endostatin has been demonstrated to influence the VEGF signal pathway by inhibiting the VEGF receptors [20] and inhibiting ischemia-induced neovascularization in mice [21] . Our study demonstrates that focal cerebral ischemia induces remarkable increase of endostatin in the brain of rabbits. Our data showed that the endostatin increased at least 50% in the ischemic brain tissue than in the normal brain tissue at the early stage after MCAO. This finding may explain the effects of endostatin on antiangiogenic responses to the cerebral ischemia, because local up-regulation of anti-angiogenic factor can be postulated as an impediment to the formation of collateral vessels.
Although there are no reports on the correlation between the endostatin and the cerebral ischemia, some studies have revealed the role of endostatin in other angiogenesis-dependent diseases such as atherosclerosis, Kawasaki disease and ischemic heart disease [22] [23] [24] . In addition, the serum endostatin has been reported to increase in several types of malignant tumor [25] [26] [27] . Lately, a study revealed that anti-endostatin monoclonal antibody could enhance the growth of human hepatocellular carcinoma cell under low oxygen conditions [28] . Considering that angiogenesis is very important in the growth and progression of malignant tumors, some researchers believe that anti-angiogenesis therapy may offer novel strategies for malignant tumor therapy [29, 30] .
The mechanism how ischemia induces endostatin instantly in the brain tissue is poorly understood. However, it is assumed easily that up-regulated endostatin may block the angiogenesis and have deleterious effect on the cerebral ischemia. Further studies are needed to confirm whether increased endostatin, and what levels of endostatin, could influence the endogenous angiogenic response after cerebral ischemia.
In addition, our study showed that both VEGF and endostatin were increased after cerebral ischemia. However, the linear correlation analysis showed that the relationship between the increase of endostatin and the concentration of VEGF was not significant.
In conclusion, as a powerful inhibitor of angiogenesis, endostatin is thought to be an important molecule linked to angiogenesis-dependent diseases. Our experiment revealed that endostatin and VEGF were both increased in penumbra zone. It may provide a theoretical basis for a new pathway, selective blocking the endostatin, to treat cerebral ischemia.
